All the trading advice you’ve ever received boils down to this

All the trading advice you’ve ever received boils down to one goal and one goal only: finding a reliable edge in the markets. If you can do that, grab hold of it and never let go. Because once you have that edge, and you can count on it, you never need to do anything else.

Drop everything and learn about the Income Calendar now.

BDTX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 9.07%

Insider Buying (Last 12 Months): $20,488,600.00

Insider Selling (Last 12 Months): $167,500.00

Black Diamond Therapeutics Insider Trading History Chart

Black Diamond Therapeutics Share Price & Price History

^$3.00

▲ +0.43 (16.73%)

As of 12/8/2023 01:00 AM ET

Days: 30 | 90 | 365

All the trading advice you’ve ever received boils down to this

From DTI Trader | Ad

Drop everything and learn about the Income Calendar now.

Black Diamond Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
10/17/2023	Growth N V Biotech	Major Shareholder	Buy	400,000	$2.34	$936,000.00	8,517,839
7/5/2023	Ali Behbahani	Director	Buy	1,000,000	$5.00	$5,000,000.00	4,448,757
6/30/2023	Growth N V Biotech	Major Shareholder	Buy	1,000,000	$5.00	$5,000,000.00	8,117,839
6/27/2023	David M Epstein	Insider	Sell	25,000	$6.70	$167,500.00	671,423
6/27/2023	Growth N V Biotech	Major Shareholder	Buy	1,740,000	$5.49	$9,552,600.00	7,117,839
10/27/2022	Growth N V Biotech	Major Shareholder	Buy	191,678	$1.87	$358,437.86	5,105,064
10/21/2022	Growth N V Biotech	Major Shareholder	Buy	87,850	$1.51	$132,653.50	4,913,386
10/19/2022	Growth N V Biotech	Major Shareholder	Buy	77,689	$1.32	$102,549.48	4,771,802
6/29/2022	Fang Ni	Insider	Buy	25,000	$2.44	$61,000.00	69,026
4/27/2022	Growth N V Biotech	Major Shareholder	Buy	150,000	$2.66	$399,000.00	4,438,402
4/18/2022	Growth N V Biotech	Major Shareholder	Buy	150,000	$3.29	$493,500.00	4,138,402
4/12/2022	Growth N V Biotech	Major Shareholder	Buy	150,000	$3.42	$513,000.00	3,885,846
5/12/2021	Brent Hatzis-Schoch	Insider	Sell	4,078	$27.42	$111,818.76	12,478
5/3/2021	Christopher D. Roberts	Insider	Sell	2,500	$26.64	$66,600.00	5,700
4/12/2021	Brent Hatzis-Schoch	Insider	Sell	4,078	$25.00	$101,950.00	12,478
4/5/2021	Christopher D. Roberts	Insider	Sell	2,500	$25.54	$63,850.00	5,700
3/3/2021	Christopher D. Roberts	Insider	Sell	2,500	$26.10	$65,250.00
2/12/2021	Brent Hatzis-Schoch	Insider	Sell	4,078	$27.23	$111,043.94	12,478
2/3/2021	Christopher D. Roberts	Insider	Sell	2,500	$25.35	$63,375.00	5,700
1/12/2021	Brent Hatzis-Schoch	Insider	Sell	11,578	$34.03	$393,999.34	12,478
1/8/2021	Thomas Leggett	CFO	Sell	3,000	$33.94	$101,820.00	3,000
1/4/2021	Christopher D. Roberts	Insider	Sell	2,500	$31.41	$78,525.00	5,700
12/14/2020	Brent Hatzis-Schoch	Insider	Sell	4,078	$34.95	$142,526.10	7,078

All the trading advice you’ve ever received boils down to this

From DTI Trader | Ad

Drop everything and learn about the Income Calendar now.

SEC Filings (Institutional Ownership Changes) for Black Diamond Therapeutics (NASDAQ:BDTX)

Institutional Buying and Selling by Quarter

Black Diamond Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
12/6/2023	Citigroup Inc.	61,348	$0.18M	0.0%	N/A	0.119%
11/21/2023	Walleye Capital LLC	15,409	$44K	0.0%	N/A	0.030%
11/14/2023	Schonfeld Strategic Advisors LLC	149,100	$0.43M	0.0%	N/A	0.289%
11/14/2023	Newtyn Management LLC	205,000	$0.59M	0.1%	+2.5%	0.397%
11/14/2023	Deerfield Management Company L.P. Series C	930,447	$2.67M	0.1%	-48.3%	1.802%
11/13/2023	CHI Advisors LLC	720,000	$2.07M	0.6%	-4.0%	1.395%
11/13/2023	Algert Global LLC	19,820	$57K	0.0%	N/A	0.038%
11/13/2023	Stifel Financial Corp	20,100	$58K	0.0%	N/A	0.039%
11/9/2023	Citigroup Inc.	61,348	$0.18M	0.0%	N/A	0.119%
11/7/2023	Barclays PLC	322,246	$0.93M	0.0%	+159.1%	0.625%
11/7/2023	Jump Financial LLC	11,272	$32K	0.0%	N/A	0.022%
8/22/2023	CHI Advisors LLC	750,000	$3.79M	1.1%	N/A	2.054%
8/15/2023	Point72 Asset Management L.P.	2,000,000	$10.10M	0.0%	N/A	5.478%
8/15/2023	RA Capital Management L.P.	3,525,754	$17.81M	0.3%	+36.1%	9.657%
8/15/2023	Kennedy Capital Management LLC	751,403	$3.80M	0.1%	N/A	2.058%
8/15/2023	Boothbay Fund Management LLC	109,293	$0.55M	0.0%	N/A	0.299%
8/14/2023	Ergoteles LLC	100,000	$0.51M	0.0%	N/A	0.274%
8/14/2023	State of Wisconsin Investment Board	12,100	$61K	0.0%	-41.0%	0.033%
8/14/2023	Bellevue Group AG	8,135,839	$41.09M	0.6%	+50.8%	22.282%
8/14/2023	Rock Springs Capital Management LP	563,233	$2.84M	0.1%	N/A	1.543%
8/14/2023	Driehaus Capital Management LLC	696,969	$3.52M	0.0%	N/A	1.909%
8/11/2023	VR Adviser LLC	353,629	$1.79M	0.3%	N/A	0.969%
8/11/2023	Renaissance Technologies LLC	220,700	$1.12M	0.0%	+1.5%	0.604%
8/11/2023	BlackRock Inc.	1,505,439	$7.60M	0.0%	+99.0%	4.123%
8/11/2023	Artal Group S.A.	2,046,517	$10.34M	0.3%	+24.3%	5.605%
8/11/2023	JPMorgan Chase & Co.	1,080,059	$5.45M	0.0%	+195,562.9%	2.958%
8/10/2023	Monashee Investment Management LLC	170,000	$0.86M	0.2%	N/A	0.466%
8/10/2023	Charles Schwab Investment Management Inc.	14,484	$73K	0.0%	N/A	0.040%
8/8/2023	Candriam S.C.A.	500,009	$2.53M	0.0%	N/A	1.370%
8/4/2023	Maven Securities LTD	187,513	$0.95M	0.0%	N/A	0.514%
8/3/2023	Barclays PLC	124,351	$0.63M	0.0%	+542.6%	0.241%
8/2/2023	Bank of Montreal Can	15,000	$76K	0.0%	N/A	0.041%
7/12/2023	Herbst Group LLC	13,635	$69K	0.0%	N/A	0.037%
7/12/2023	Beacon Capital Management LLC	15,615	$79K	0.0%	-56.2%	0.043%
7/10/2023	AE Wealth Management LLC	15,920	$80K	0.0%	-55.7%	0.044%
5/15/2023	EcoR1 Capital LLC	1,191,094	$2.25M	0.1%	+322.2%	3.263%
5/15/2023	Two Sigma Advisers LP	175,900	$0.33M	0.0%	-17.2%	0.482%
5/15/2023	Two Sigma Investments LP	107,754	$0.20M	0.0%	-25.0%	0.295%
5/12/2023	BlackRock Inc.	756,387	$1.43M	0.0%	-23.9%	2.072%
5/12/2023	Dimensional Fund Advisors LP	25,920	$49K	0.0%	-50.6%	0.071%
5/8/2023	Federated Hermes Inc.	13,185	$25K	0.0%	-91.5%	0.036%
2/15/2023	State of Wisconsin Investment Board	41,200	$74K	0.0%	-36.1%	0.113%
2/15/2023	Millennium Management LLC	524,557	$0.94M	0.0%	+51.2%	1.442%
2/15/2023	Morgan Stanley	31,202	$56K	0.0%	-86.4%	0.086%
2/14/2023	Susquehanna International Group LLP	65,814	$0.12M	0.0%	-30.9%	0.181%
2/14/2023	Two Sigma Investments LP	143,664	$0.26M	0.0%	-30.9%	0.395%
2/14/2023	EcoR1 Capital LLC	282,131	$0.51M	0.0%	N/A	0.776%
2/10/2023	K2 Principal Fund L.P.	158,192	$0.29M	0.0%	-84.7%	0.435%
2/9/2023	Dimensional Fund Advisors LP	52,522	$95K	0.0%	-12.5%	0.144%
1/12/2023	Marquette Asset Management LLC	34,400	$62K	0.0%	N/A	0.095%
11/15/2022	Two Sigma Advisers LP	214,600	$0.36M	0.0%	-20.0%	0.590%
11/15/2022	Two Sigma Investments LP	207,893	$0.35M	0.0%	-20.2%	0.572%
11/15/2022	Vanguard Group Inc.	757,098	$1.28M	0.0%	+13.9%	2.082%
11/15/2022	BlackRock Inc.	1,263,517	$2.14M	0.0%	-0.7%	3.474%
11/14/2022	Renaissance Technologies LLC	217,700	$0.37M	0.0%	-20.0%	0.599%
11/14/2022	Ergoteles LLC	50,347	$85K	0.0%	-54.2%	0.138%
11/10/2022	Connor Clark & Lunn Investment Management Ltd.	82,881	$0.14M	0.0%	+572.2%	0.228%
11/10/2022	Dimensional Fund Advisors LP	60,046	$0.10M	0.0%	N/A	0.165%
10/18/2022	Bailard Inc.	21,281	$36K	0.0%	-63.6%	0.059%
10/5/2022	Beacon Capital Management LLC	35,615	$88K	0.0%	+48.4%	0.098%
9/16/2022	Federated Hermes Inc.	159,548	$0.39M	0.0%	-84.6%	0.439%
8/18/2022	Goldman Sachs Group Inc.	102,126	$0.25M	0.0%	-43.6%	0.281%
8/15/2022	Occudo Quantitative Strategies LP	19,807	$49K	0.0%	-27.0%	0.055%
8/15/2022	AQR Capital Management LLC	18,663	$46K	0.0%	+34.4%	0.051%
8/15/2022	State Street Corp	76,384	$0.19M	0.0%	-79.3%	0.210%
8/15/2022	Cubist Systematic Strategies LLC	15,804	$39K	0.0%	+25.8%	0.043%
8/15/2022	Millennium Management LLC	247,540	$0.61M	0.0%	N/A	0.681%
8/13/2022	Renaissance Technologies LLC	272,002	$0.67M	0.0%	+2.8%	0.750%
8/12/2022	Northern Trust Corp	37,838	$93K	0.0%	-80.1%	0.104%
8/11/2022	Healthcare of Ontario Pension Plan Trust Fund	73,100	$0.18M	0.0%	-79.5%	0.201%
8/11/2022	UBS Group AG	17,599	$44K	0.0%	-15.5%	0.048%
8/5/2022	Connor Clark & Lunn Investment Management Ltd.	12,330	$30K	0.0%	N/A	0.034%
8/3/2022	AE Wealth Management LLC	36,385	$90K	0.0%	+45.8%	0.100%
7/27/2022	Bailard Inc.	58,500	$0.14M	0.0%	N/A	0.161%
5/16/2022	Goldman Sachs Group Inc.	181,097	$0.50M	0.0%	+37.0%	0.499%
5/16/2022	PDT Partners LLC	66,168	$0.18M	0.0%	-10.6%	0.182%
5/16/2022	UBS Group AG	20,820	$58K	0.0%	-29.6%	0.057%
5/13/2022	Renaissance Technologies LLC	264,491	$0.73M	0.0%	-31.4%	0.729%
5/13/2022	Bellevue Group AG	3,293,000	$9.12M	0.1%	-4.9%	9.075%
5/13/2022	Northern Trust Corp	189,946	$0.53M	0.0%	-5.7%	0.523%
5/13/2022	Charles Schwab Investment Management Inc.	48,287	$0.13M	0.0%	-19.9%	0.133%
5/13/2022	Vanguard Group Inc.	676,687	$1.88M	0.0%	-33.3%	1.865%
5/12/2022	BlackRock Inc.	2,329,164	$6.45M	0.0%	+3.6%	6.419%
5/12/2022	Healthcare of Ontario Pension Plan Trust Fund	357,100	$0.99M	0.0%	+376.1%	0.984%
5/11/2022	JPMorgan Chase & Co.	260,472	$0.72M	0.0%	+31.8%	0.718%
5/6/2022	Los Angeles Capital Management LLC	88,887	$0.25M	0.0%	+63.8%	0.245%
4/18/2022	AE Wealth Management LLC	24,963	$69K	0.0%	+54.7%	0.069%
2/14/2022	PDT Partners LLC	74,036	$0.40M	0.0%	-27.3%	0.204%
2/14/2022	DAFNA Capital Management LLC	206,100	$1.10M	0.3%	N/A	0.569%
2/11/2022	Bioimpact Capital LLC	239,888	$1.28M	0.2%	-3.5%	0.662%
2/3/2022	Cambridge Investment Research Advisors Inc.	11,031	$59K	0.0%	N/A	0.030%
2/2/2022	New York State Common Retirement Fund	10,694	$57K	0.0%	-36.0%	0.030%
1/20/2022	AE Wealth Management LLC	16,135	$86K	0.0%	N/A	0.045%
11/16/2021	Schonfeld Strategic Advisors LLC	14,900	$0.13M	0.0%	-47.7%	0.041%
11/16/2021	Squarepoint Ops LLC	20,092	$0.17M	0.0%	N/A	0.055%
11/16/2021	Two Sigma Advisers LP	181,300	$1.53M	0.0%	+115.3%	0.500%
11/16/2021	Two Sigma Investments LP	296,806	$2.51M	0.0%	-28.3%	0.819%
11/16/2021	Voloridge Investment Management LLC	137,441	$1.16M	0.0%	+8.9%	0.379%
11/16/2021	BioImpact Capital LLC	248,506	$2.10M	0.3%	N/A	0.686%
11/15/2021	Deerfield Management Company L.P. Series C	760,128	$6.43M	0.1%	-27.4%	2.098%

Data available starting January 2016

Black Diamond Therapeutics, Inc., a clinical-stage precision oncology medicine company, focuses on the discovery and development of therapies for patients with genetically defined cancers. The company's lead product candidate, BDTX-1535, a brain-penetrant, mutant selective, irreversible EGFR MasterKey inhibitor, designed to inhibit a family of oncogenic mutations, currently under Phase 1 clinical trial. It also develops BDTX-4933, a brain penetrant RAF MasterKey inhibitor, designed to be a brain penetrant and highly selective and potent inhibitor of oncogenic BRAF Class I, II, III and active RAF dimers, expected to initiate Phase 1 clinical trial. The company was formerly known as ASET Therapeutics, Inc. and changed its name to Black Diamond Therapeutics, Inc. in January 2018. Black Diamond Therapeutics, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.

Today's Range

Now: $3.00

$2.53

$3.03

50 Day Range

MA: $2.21

$1.77

$3.00

52 Week Range

Now: $3.00

$1.22

$6.85

Volume

1,403,748 shs

Average Volume

330,342 shs

Market Capitalization

$154.89 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.55

Who are the company insiders with the largest holdings of Black Diamond Therapeutics?: Black Diamond Therapeutics' top insider shareholders include:
Growth N V Biotech (Major Shareholder)
Ali Behbahani (Director)
David M Epstein (Insider)
Fang Ni (Insider)
Learn More about top insider investors at Black Diamond Therapeutics.
Who are the major institutional investors of Black Diamond Therapeutics?: Black Diamond Therapeutics' top institutional shareholders include:
Deerfield Management Company L.P. Series C — 1.80%
CHI Advisors LLC — 1.39%
Barclays PLC — 0.62%
Newtyn Management LLC — 0.40%
Schonfeld Strategic Advisors LLC — 0.29%
Citigroup Inc. — 0.12%
Learn More about top institutional investors of Black Diamond Therapeutics stock.
Which major investors are selling Black Diamond Therapeutics stock?: During the last quarter, BDTX stock was sold by these institutional investors:
Deerfield Management Company L.P. Series C
CHI Advisors LLC
Ausdal Financial Partners Inc.
Which major investors are buying Black Diamond Therapeutics stock?: In the previous quarter, BDTX stock was purchased by institutional investors including:
Barclays PLC
Schonfeld Strategic Advisors LLC
Citigroup Inc.
Citigroup Inc.
Stifel Financial Corp
Algert Global LLC
Walleye Capital LLC
Jump Financial LLC
In the last year, these company insiders have bought Black Diamond Therapeutics stock:
Growth N V Biotech (Major Shareholder)
Ali Behbahani (Director)
David M Epstein (Insider)
Learn More investors buying Black Diamond Therapeutics stock.

All the trading advice you’ve ever received boils down to this

From DTI Trader | Ad

Drop everything and learn about the Income Calendar now.

BDTX Insider Trading

Black Diamond Therapeutics Insider Trading History Chart

Black Diamond Therapeutics Share Price & Price History

Black Diamond Therapeutics Insider Trading History

SEC Filings (Institutional Ownership Changes) for Black Diamond Therapeutics (NASDAQ:BDTX)

Institutional Buying and Selling by Quarter

Black Diamond Therapeutics Institutional Trading History

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Who are the company insiders with the largest holdings of Black Diamond Therapeutics?

Who are the major institutional investors of Black Diamond Therapeutics?

Which major investors are selling Black Diamond Therapeutics stock?

Which major investors are buying Black Diamond Therapeutics stock?